Amubarvimab Antibody

SKU: orb1980540

Description

Amubarvimab (BRII-196) is a humanized monoclonal antibody that neutralizes SARS-CoV-2 by binding to the virus's spike protein. It has been investigated in both in vitro antiviral assays and in vivo preclinical models for the treatment of COVID-19.

Research Area

Infectious Disease & Virology

Images & Validation

−

Key Properties

−

CAS Number	2509447-07-6
MW	143.84 kDa
Purity	95.00%
Target	SARS-CoV

Bioactivity

−

In Vitro	Amubarvimab is a human IgG1 mAb that binds to a non-competing epitope on the spike protein receptor binding domain (RBD) with a KD of 5.88 nM.

Storage & Handling

−

Storage	Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Alternative Names

−

BRII196, BRII-196

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Quick Database Links

Gene Symbol

SARS-CoV

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols